SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001056520-14-000207
Filing Date
2014-11-19
Accepted
2014-11-19 10:36:54
Documents
9
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q cellcyteform10qsept302014fin.htm 10-Q 262728
2 EX-31 exhibit31.htm EX-31 12323
3 EX-32 exhibit32.htm EX-32 5049
  Complete submission text file 0001056520-14-000207.txt   1351414

Data Files

Seq Description Document Type Size
4 INSTANCE ccyg-20140930.xml EX-101.INS 122758
5 SCHEMA ccyg-20140930.xsd EX-101.SCH 9732
6 CALCULATION ccyg-20140930_cal.xml EX-101.CAL 11842
7 DEFINITION ccyg-20140930_def.xml EX-101.DEF 7832
8 LABEL ccyg-20140930_lab.xml EX-101.LAB 99839
9 PRESENTATION ccyg-20140930_pre.xml EX-101.PRE 74486
Mailing Address PMB189 14205 SE 36TH, SUITE 100 BELLEVUE WA 98006
Business Address PMB189 14205 SE 36TH, SUITE 100 BELLEVUE WA 98006 425-519-3755
CELLCYTE GENETICS CORP (Filer) CIK: 0001325279 (see all company filings)

IRS No.: 861127046 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52238 | Film No.: 141233957
SIC: 2834 Pharmaceutical Preparations